Funding Opportunity:

The Indiana University Cooperative Center of Excellence in Hematology (CCEH) announces the availability of a funding opportunity through the Pilot and Feasibility program of the Center. Applications should focus on the molecular and cellular biology of normal (non-malignant) murine and human hematopoietic stem and progenitor cell regulation and the hematopoietic parameters impacting the efficient use of these cells in transplantation such as homing, cell cycle regulation, and the status of the hematopoietic niche. Applications will be reviewed by an internal review committee and rankings will be completed based on significance, innovation, approach, feasibility, and the prospect of obtaining extramural funding for the proposed project.

Eligibility: IU faculty (at all IU campuses) at the rank of Assistant or Associate Professor or an equivalent Research rank. Investigators with outside funding can apply provided there is no overlap between their funded research and the proposal submitted for this mechanism.

Important deadlines and other information:

“TBA”: Deadline for receiving a complete application as a single pdf file containing:

  1. An abstract of the proposed project
  2. A four-page NIH biosketch for key personnel
  3. Other support
  4. A three-page project proposal (including tables and figures and excluding references)
  5. All required approvals for human and animal use and IBC approvals if required.
  6. Appendices are not permitted

Applicants will be informed of the review outcome by “TBA”.

Funding of approved applications will begin “TBA” for a period of one year.

Funding for a maximum of $15,000 should be requested for supplies and fees. No salary support for any personnel is permitted. Funding is for one year. Applicants are expected to submit a detailed progress report at the end of their funding period.

Please send your documents electronically (a single pdf containing all the required forms) to Edward F. Srour, Ph.D. and April D. Maines by 5pm “TBA”.